ClinicalTrials.gg
Not yet recruitingNCT07946237Optimizing CouUpdated Nov 18, 2026

Optimizing Cough Rehabilitation Through Combined Cough Skill Training and Transcutaneous Spinal Cord Stimulation

An interventional study of transcutaneous spinal direct current stimulation and Cough Skill Training in Healthy Adult, Rehabilitation Exercise and Electric Stimulation Therapy, sponsored by University of Florida. Not yet recruiting at 1 site in United States. Open to participants aged 40 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University of Florida · Not applicable, Interventional, and Treatment

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
40 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 104 studies in Cough with a site in United States — 18 open to participants now, 22 under way, 1 of them phase 3. Cough · United States.

Planned enrollment
72nd of 86
16 · median 63
Started
2026
with 5 others
No phase
32 of 104
9 open now
Primary completion
2027-09
later than 13 of 21 live
Registered
104th of 104
by date
Lead sponsor
7 of 104
University of Florida

Among the 104 studies in Cough with a site in United States, this one is the 72nd largest by planned enrollment of the 86 interventional ones that give a count, is one of 6 that started in 2026, is one of 32 with no phase, reaches primary completion later than 13 of the 21 other live ones, and was the 104th registered.

Cough

429 studies on the registry are indexed under Cough; 69 are open to participants now.

Browse Cough studies →

Open to participants now

18 of the 104 studies in Cough with a site in United States are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 46 Cough studies recruiting now, 20 (43%) set no upper age limit and 14 (30%) stop at 75 or younger; 10 take children under 18; 6 take healthy volunteers.

This study: 40 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 104 studies in Cough with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to evaluate the effects of combining cough training with low-level electrical stimulation to the neck (tsDCS) in healthy adults and adults with neurological diseases. The main questions it aims to answer are:

  • Is using tsDCS during cough training safe, tolerable, and acceptable to participants?
  • What tsDCS settings are most effective for pairing with cough training? Researchers will compare sham stimulation with active tsDCS to see if tsDCS enhances cough gains. Before and after each testing session, participants will complete breathing, coughing, and respiratory-strength training.
Read the detailed description

Study Purpose and Background People with neurodegenerative diseases frequently experience reduced cough function (hypotussia) and swallowing difficulties (dysphagia), which negatively impact quality of life and increase the risk of pneumonia, a leading cause of death in these populations. While behavioral exercises like cough training can help improve airway protection, people with these diseases often struggle to perform them with the high intensity required to trigger lasting brain and nerve adaptation (neuroplasticity).

To overcome this limitation, this pilot study investigates a novel, non-invasive combinatorial approach: pairing Cough Skill Training (CST) with transcutaneous spinal direct current stimulation (tsDCS) applied to the neck. The theory is that spinal stimulation enhances communication between the brain and muscles, optimizing the outcomes of training. Because this combined intervention has not been tested before, this initial research aims to establish its overall feasibility and compare different stimulation settings in healthy adults before future translation to clinical patient populations.

Study Design and Methods This study is an initial pilot trial utilizing a randomized crossover design involving 16 healthy adult participants aged 40 to 85 years with normal respiratory function.

  • Screening \& Familiarization (Visit 1): Participants undergo baseline screening, including health history reviews and spirometry (pulmonary function testing). They are also familiarized with the testing and training activities.
  • Intervention Sessions: Across separate intervention visits separated by a 6-week washout period, participants receive 20 minutes of neck-based tsDCS paired with CST. During active stimulation, current is delivered continuously, whereas sham stimulation provides brief ramping periods without sustained current. CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak).
  • Assessments: Researchers record vital signs, breathing tests, airway occlusions (to measure drive to breathe), maximum respiratory pressure tests. Exploratory measures, such as saliva swallowing patterns and how long participants can produce a vowel sound, are also tracked.

Aims:

  • Aim 1: Feasibility and acceptability will be evaluated by the participants' ability to complete all training tasks simultaneously with stimulation, scores from the Acceptability of Intervention Measure (AIM), participant ability to blind/detect sham versus active treatment, and perceived exertion, task difficulty, and stimulation intensity ratings.
  • Aim 2: Cough and respiratory performance will be measured by the change in cough peak expiratory flow rate (PEFR) from baseline, along with CST performance accuracy, other cough, resting breathing, and respiratory strength parameters.
03

Conditions studied

  • Healthy Adult
  • Rehabilitation Exercise
  • Electric Stimulation Therapy
  • Cough Peak Flow
  • Ventilatory Function

Browse trials for

Keywords

  • cough
  • transcutaneous spinal direct current stimulation
  • airway protection
  • ventilatory drive
  • cervical spinal stimulation
04

Who can participate

Ages eligible
40 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Forced vital capacity (FVC) ≥ 80% predicted based on age/sex

Exclusion criteria

Exclusion Criteria:

  • neurological disease
  • respiratory disease including acute respiratory infection with cough during past week
  • Pregnancy
  • metallic implants in the spine
  • cardiac pacemaker
  • use of sodium channel blockers, calcium channel blockers, and/or NMDA receptor antagonists
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
16 participants (estimated)

Study arms

  • Sham comparator
    Sham Stimulation

    Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session.

    Behavioral: Cough Skill Training · Device: Sham stimulation

  • Experimental
    Cathodal Stimulation

    Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes.

    Device: transcutaneous spinal direct current stimulation · Behavioral: Cough Skill Training

  • Experimental
    Anodal Stimulation

    Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes.

    Device: transcutaneous spinal direct current stimulation · Behavioral: Cough Skill Training

Interventions

  • Devicetranscutaneous spinal direct current stimulation

    Transcutaneous spinal cord stimulation at 2mA intensity, for 20 minutes.

  • BehavioralCough Skill Training

    CST involves visual feedback on a computer screen to guide participants through coughing at specific target ranges (strong, moderate, and weak).

  • DeviceSham stimulation

    Transcutaneous spinal cord stimulation at reduced intensity, lasting 1 minute at the beginning and end of a 20-minute session.

06

What researchers measure

Primary outcomes

  1. Completion of training tasks with simultaneous stimulation

    Measured as percentage of sessions in which both interventions can be completed simultaneously.

    Time frame: During training

  2. Peak Cough Flow

    The highest rate of airflow generated during a volitional cough

    Time frame: Baseline, immediate post-single-treatment measurement

Secondary outcomes

  1. Acceptability of Intervention Measure (AIM)

    Participants will rate favorability of treatment procedures. This scale consists of 4 items rating acceptability using a 1-5 Likert Scale, with a combined total score range of 4-20. A score of 1 represents "completely disagree," and a score of 5 represents "completely agree." Thus, a higher score reflects a more favorable experience.

    Time frame: Immediate post-single-treatment measurement

Other outcomes

  1. Airway occlusion pressure (P0.1)

    The change in air pressure at the opening of the airway (mouth and nose) in the first 100 ms of a breath. This estimates neural drive to breathe.

    Time frame: Baseline vs immediate post-single-treatment

07

Study locations

1 site
08

References and documents

Publications

  • Nierat MC, Similowski T, Lamy JC. Does trans-spinal direct current stimulation alter phrenic motoneurons and respiratory neuromechanical outputs in humans? A double-blind, sham-controlled, randomized, crossover study. J Neurosci. 2014 Oct 22;34(43):14420-9. doi: 10.1523/JNEUROSCI.1288-14.2014. PubMed 25339753 ↗
  • Delucenay-Clarke R, Nierat MC, Frugiere A, Similowski T, Cayetanot F, Bodineau L. Direct current stimulation as a non-invasive therapeutic alternative for treating autonomic or non-autonomic neurological disorders affecting breathing. Clin Auton Res. 2024 Aug;34(4):395-411. doi: 10.1007/s10286-024-01055-y. Epub 2024 Aug 12. PubMed 39133345 ↗
  • Clark DJ, Hawkins KA, Winesett SP, Cox BA, Pesquera S, Miles JW, Fuller DD, Fox EJ. Enhancing Locomotor Learning With Transcutaneous Spinal Electrical Stimulation and Somatosensory Augmentation: A Pilot Randomized Controlled Trial in Older Adults. Front Aging Neurosci. 2022 Mar 2;14:837467. doi: 10.3389/fnagi.2022.837467. eCollection 2022. PubMed 35309891 ↗
  • Borders JC, Villarreal-Cavazos K, Huber JE, Quinn L, Keller B, Troche MS. Enhancing Cough Motor Learning in Parkinson's Disease Through Variable Practice During Skill Training. Mov Disord Clin Pract. 2024 Dec;11(12):1500-1515. doi: 10.1002/mdc3.14218. Epub 2024 Oct 8. PubMed 39377552 ↗
  • Benussi A, Cantoni V, Grassi M, Libri I, Cotelli MS, Tarantino B, Datta A, Thomas C, Huber N, Karkkainen S, Herukka SK, Haapasalo A, Filosto M, Padovani A, Borroni B. Cortico-spinal tDCS in amyotrophic lateral sclerosis: A randomized, double-blind, sham-controlled trial followed by an open-label phase. Brain Stimul. 2023 Nov-Dec;16(6):1666-1676. doi: 10.1016/j.brs.2023.11.008. Epub 2023 Nov 15. PubMed 37977335 ↗

Individual participant data

Plan to share: Yes — Participant data that underlie the results reported in this article after deidentification.

Supporting information: Study protocol

Time frame: 9 months and ending 36 months following article publication.

Access criteria: Investigators whose proposed use of the data has been approved by an independent review committee.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Sep 2027, 9 months later.

Of 79 non-industry interventional studies with no phase under Cough, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's planned 9 months is below that.

Counting every sponsor, half of 87 studies reached it within 15 months; a quarter within 6 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Nov 18, 2026
StartEst.
Dec 2026
Primary completionEst.
Sep 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07946237
Collaborators
American Speech-Language-Hearing Foundation
Responsible party
Sponsor
First posted
Nov 18, 2026
Start date
Dec 2026 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

May Smith-Hublou, PhD, SLP
Contact
maysmith@ufl.edu
352-273-6855
Barbara K Smith, PhD, PT
Contact
352-294-5315
May Smith-Hublou, PhD
principal investigator · University of Florida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion